A new mobile phone app being trialled at Mater Mothers’ Hospital Brisbane aims to reduce the rate of stillbirth in Australia by 30 per cent by focusing on a baby’s kicks.
A new triple-combination drug trialled at Mater in Brisbane could increase the life expectancy of patients with cystic fibrosis (CF).
Mater Researcher Dr Jake Gratten has received more than $98,000 in funding to progress research into anxiety and gastrointestinal disorders in autistic children.
Following an international search, Professor Maher Gandhi has been appointed Director of Clinical Research at Mater Research.